Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07438041 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Linking Youth to Pre-Exposure Prophylaxis (PrEP) Services

Study acronym: LYPS
StatusRecruiting
PhaseNot applicable
SponsorWestat
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Recruitment opened Start date: Jul 27, 2026 to Oct 15, 2026 · Eligibility criteria expanded, about 13 words · Secondary endpoints: details revised at 2 of 2 entries · 2 more Show 5 more changesShow less
    • Start date: Jul 27, 2026 to Oct 15, 2026
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 2 of 2 entries
    • Study description revised
    • Site details revised at 4 of 4 sites
  2. Notable Start date: May 2026 to Jul 27, 2026 Primary completion pushed from Mar 2028 to Aug 15, 2028 · Completion date: Dec 2028 to Dec 15, 2028v3 Show 2 more changesShow less
    • Primary completion pushed from Mar 2028 to Aug 15, 2028
    • Completion date: Dec 2028 to Dec 15, 2028
  3. Notable Start date: Mar 2026 to May 2026v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
6 trials monitored
See 1 trial at risk
The LYPS intervention is a multi-level intervention that combines: a) structural-level delivery of PrEP and PrEP services by a community health professional (CHP) at a designated place in the community being offered by the SC where PrEP is not yet provided (e.g., participant's home, community partner location, or traveling mobile van), with b) an individual-level mobile application (app) to support PrEP adherence and persistence between CHP visits.
Trial Details
NCT Number NCT07438041
Lead Sponsor Westat
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH), National Institutes of Health (NIH), Florida State University, The Emmes Company, LLC
Conditions HIV, PrEP, PrEP Adherence
Enrollment 272 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov